Skip to main content

Triumph Capital Management

Position in LLY — ELI LILLY & Co

CIK 1730765 DENVER, CO

Position in LLY

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$3,643,868
+$1,468,612 QoQ
Shares Held
3,038
+28.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#1,963
of 4,605 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Triumph Capital Management holds $8,936,522 across 15 Drug Manufacturers - General names. LLY ranks #1 (40.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
3,038 $3,643,868

All Filings in LLY

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,643,868 3,038
2026-03-31 $2,175,256 2,365
2025-12-31 $1,630,289 1,517
2025-09-30 $3,290,819 4,313
2025-06-30 $2,359,637 3,027
2025-03-31 $972,096 1,177
2024-12-31 $1,062,272 1,376
2024-09-30 $1,059,584 1,196
2024-06-30 $602,077 665
2024-03-31 $595,917 766
2023-12-31 $1,305,740 2,240
2023-09-30 $455,486 848
2023-06-30 $393,005 838
2023-03-31 $413,821 1,205
2022-12-31 $320,475 876
2022-03-31 $577,035 2,015
2021-12-31 $695,798 2,519
2021-09-30 $838,711 3,630